| Dr Angelo Santos, PHARMDD | |
|
58 Plaistow Rd, Plaistow, NH 03865-2831 | |
| (603) 382-2844 | |
| Not Available |
| Full Name | Dr Angelo Santos |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 58 Plaistow Rd, Plaistow, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376755702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3480 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angelo Santos, PHARMDD 409 Aiken Ave, Dracut, MA 01826-5034 Ph: (978) 758-7390 | Dr Angelo Santos, PHARMDD 58 Plaistow Rd, Plaistow, NH 03865-2831 Ph: (603) 382-2844 |
News Archive
They're ba-ack! But in a new disease-fighting role. Viruses that infect and kill bacteria - used to treat infections in the pre-antibiotic era a century ago and in the former Soviet Union today - may have a new role in preventing formation of the sticky "biofilms" of bacteria responsible for infections on implanted medical devices.
Solta Medical, Inc., the pioneer in fractional resurfacing and non-invasive skin tightening and a market leader in aesthetic skin treatments, today announced Health Canada approval of its Thermage CPT™ and Fraxel re:store® Dual systems. These products are now available to physicians in Canada. In the fall of 2009, the company received U.S. FDA clearance to market and sell both the Thermage CPT and Fraxel re:store Dual systems. Both systems are now available in over 100 countries worldwide.
Using the Hazard Analysis of Critical Control Points (HACCP) framework, researchers assessed the risk and mitigation strategies for universities with students returning to campus. The methodology allowed a rapid response to curb disease transmission with continuing education.
Ocera Therapeutics, Inc. announced today that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients with liver cirrhosis. OCR-002 recently received Orphan Drug status and Fast Track designation by the United States Food and Drug Administration for the treatment of hyperammonemia (excessive ammonia levels) and resultant Hepatic encephalopathy.
› Verified 3 days ago
Sara Lynn Tolliday, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Plaistow Rd, Plaistow, NH 03865 Phone: 603-382-5885 | |
Jiyoung Hwang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 58 Plaistow Rd, Plaistow, NH 03865 Phone: 603-382-2839 | |
Beth Perras, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Plaistow Rd, Plaistow, NH 03865 Phone: 603-382-5885 Fax: 603-382-3147 | |
Ms. Brianna Leigh Mitchell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Plaistow Rd, Plaistow, NH 03865 Phone: 603-382-5885 | |
Dr. Vadim Evstifeev, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 58 Plaistow Rd, Plaistow, NH 03865 Phone: 603-382-2844 | |
Dr. Andria Marie Buco, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31 Garden Rd, Plaistow, NH 03865 Phone: 603-382-9217 Fax: 603-382-8627 | |
Sarah Ekbatani, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Plaistow Rd, Plaistow, NH 03865 Phone: 603-382-5885 |